Chrysalis Day Program Body Mass Index Study
This is a study to determine if the approach taken to treat patients in the Chrysalis Day Hospital Program will favourably effect their health status as assessed by Body Mass Index (BMI)
Borderline Personality Disorder
Behavioral: Chrysalis Day Program
|Study Design:||Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||A Study on the Effects of a Personality Disorder Day Hospital Program on Clients Body Mass Index|
- Body Mass Index at time of enrolling in programme and at leaving [ Time Frame: at entry and upon leaving the program ]
- patient demographics relationship to outcome [ Time Frame: upon entry and exit from the program ]
- programme changes and relation to outcome [ Time Frame: from start to the end of the study ]
|Study Start Date:||October 2001|
|Study Completion Date:||June 2007|
As part of the Providence Continuing Care Center's continuing quality improvement initiatives this study is to more systematically evaluate the success of the Chrysalis Day Hospital Program in dealing with some features of eating disorders commonly experienced by its patients.
At intake all clients will be approached to give informed consent to participate. If they do consent they will have their height and weight recorded( if they request they will not be told their weight)as part of the usual intake process conducted by a dietician.
When clients exit the program they again will be approached to be weighed. The body mass index will be calculated and compared to admission values.
The Chrysalis Program is a unique day hospital approach to treating individuals with severe personality disorders (primarily Borderline)that views the eating disordered behaviour common to these clients as a symptom of many and by addressing core issues of affect dysregulation as well as psychoeducation about eating the eating problems will improve .
|Providence Care Centre Mental Health Services|
|Kingston, Ontario, Canada, K7L 4X3|
|Principal Investigator:||Stephen H McNevin, MD||Queens University|